GoldenGolden
Intarcia Therapeutics

Intarcia Therapeutics

Formerly BioMedicines, Intarcia Therapeutics is an American biopharmaceutical company developing therapies for diseases with long-term treatment requirements.

Intarcia Therapeutics, Inc. is a biopharmaceutical company that is committed to developing innovative therapies by using a proprietary delivery system and medicines that have the potential to change the prevention and management of severe chronic diseases.

Intarcia comprises of entrepreneurial and talented people who collaborate and achieve meaningful results. Its innovative technology platform, the Medici Drug Delivery System™, is being developed with almost two decades of visionary collaboration between a group of scientists and entrepreneurs.

Intarcia is developing its Medici Drug Delivery System™, bridging technology and medicine, to transform the treatment and prevention of chronic disease.

Intarcia’s pre-clinical candidate, ITCA 650/12M, is used for the treatment of type 2 diabetes. Exenatide, the active agent of ITCA 650/12M, is a glucagon-like peptide-1 (GLP-1) receptor agonist (RA) is presently being developed for the treatment of T2D by delivering annual dosing of exenatide via the Medici System.

Intarcia is working to develop once-yearly anti-HIV prophylactic therapy for delivery via the Medici System through a collaboration with the Bill & Melinda Gates Foundation, and the goal is to help prevent the spread of HIV in Sub-Saharan Africa and other regions that are impacted by the HIV epidemic.

Timeline

September 27, 2017
Intarcia Therapeutics raises a $200,000,000 series E round.
March 20, 2007
Intarcia Therapeutics raises a $50,000,000 series B round from Alta Partners, New Enterprise Associates and Omega Funds.

Funding rounds

People

Name
Role
LinkedIn

David Franklin

Co-Founder

Aaron Lazor

Employee

Amy Gussin

Employee

Andreas Huber

Investor

Bonny Hsieh

Employee

Carrie Tsunemoto

Employee

Christina Regis - Product Manager

Employee

James M. Ahlers

Co-Founder

Jason Banks

Employee

Jennifer Doan

Employee

Jeroen Grasman

Employee

Jim Pallotta

Investor

Joe Ventosa

Employee

Joshua Langsam

Investor

Justin Beavers

Investor

Kris Patel

Employee

Liat Aaronson

Investor

Paul Henriques

Employee

Rajeshwari Kantamneni

Employee

Raymond Chang

Investor

Spencer Little

Employee

Tania Khan

Employee

Ted Reyes

Employee

Thet Mon Pyone

Employee

Thomas Alessi

Co-Founder

Page 1 of 2

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.